LOUIS SULLIVAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LOUIS SULLIVAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOUIS SULLIVAN. LOUIS SULLIVAN is a Director in HENRY SCHEIN INC ($HSIC) and a Director in UNITED THERAPEUTICS Corp ($UTHR) and a Director in ANI PHARMACEUTICALS INC ($ANIP) and a Director in Emergent BioSolutions Inc. ($EBS).
Companies in which LOUIS SULLIVAN is an Insider
ANI PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS SULLIVAN: Director
Holdings: 14,413 shares
Current Value: $895,912
Latest Transaction: Sep 12 2003
$ANIP Market Capitalization: $718.77M
$ANIP Previous Close: $62.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Emergent BioSolutions Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS SULLIVAN: Director
Holdings: 43,063 shares
Current Value: $1,263,899
Latest Transaction: May 11 2021
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HENRY SCHEIN INC
Industry: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
Position of LOUIS SULLIVAN: Director
Holdings: 14,096 shares
Current Value: $2,311,462
Latest Transaction: Apr 04 2016
$HSIC Market Capitalization: $13.17B
$HSIC Previous Close: $163.98
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
UNITED THERAPEUTICS Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS SULLIVAN: Director
Holdings: 11,100 shares
Current Value: $1,807,302
Latest Transaction: Jun 28 2021
$UTHR Market Capitalization: $6.99B
$UTHR Previous Close: $162.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of LOUIS SULLIVAN
Sentiment: All, ANIP, EBS, HSIC, UTHR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 0.00 | 1,680 | 0 | 0 | |
| Jun 28 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 0.00 | 1,680 | 0 | 11,100 | 9.4 K to 11.1 K (+17.83 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 88.03 | 15,000 | 1,320,450 | 0 | |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 63.90 | 15,000 | 958,500 | 0 | |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 194.30 | 15,000 | 2,914,500 | 9,420 | 24.4 K to 9.4 K (-61.43 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Buy | M | 88.03 | 15,000 | 1,320,450 | 24,420 | 9.4 K to 24.4 K (+159.24 %) |
| May 12 2021 | UTHR | UNITED THERAPEUTIC ... | SULLIVAN LOUIS W | Director | Sell | D | 194.30 | 15,000 | 2,914,500 | 9,420 | 24.4 K to 9.4 K (-61.43 %) |